Home
>
National Drug Code (NDC)
>
EMBEDA
EMBEDA - 60793-435-01 - (MORPHINE SULFATE and NALTREXONE HYDROCHLORIDE)
Drug Information of EMBEDA
| Product NDC: | 60793-435 |
| Proprietary Name: | EMBEDA |
| Non Proprietary Name: | MORPHINE SULFATE and NALTREXONE HYDROCHLORIDE |
| Active Ingredient(s): | 80; 3.2 mg/1; mg/1 & nbsp; MORPHINE SULFATE and NALTREXONE HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of EMBEDA
| Product NDC: | 60793-435 |
| Labeler Name: | King Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022321 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090813 |
Package Information of EMBEDA
| Package NDC: | 60793-435-01 |
| Package Description: | 200 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60793-435-01) |
NDC Information of EMBEDA
| NDC Code | 60793-435-01 |
| Proprietary Name | EMBEDA |
| Package Description | 200 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60793-435-01) |
| Product NDC | 60793-435 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | MORPHINE SULFATE and NALTREXONE HYDROCHLORIDE |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20090813 |
| Marketing Category Name | NDA |
| Labeler Name | King Pharmaceuticals, Inc. |
| Substance Name | MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE |
| Strength Number | 80; 3.2 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
